Publications

5808 Results

Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) and radiation therapy (RT) for locally advanced non-small cell lung carcinoma of the lung (NSCLC).

Authors
R Byhardt;C Scott;W Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton
Journal / Conference
Int J Radiat Oncol Biol Phys 39:195(#120)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Intensified treatment increases survival in patients with non-small cell lung cancer at what place? A quality adjusted survival analysis of radiation therapy oncology group chemoradiation studies.

Authors
C Scott;B Movsas;WT Sause;R Byhardt;R Komaki;J Cox;DS Johnson;C Lawton;R Dar;T Wasserman;M Roach;JS Lee;EJ Andras
Journal / Conference
Quality of Life Research 6:718(#345)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Addition of chemotherapy to radiation therapy alter failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials.

Authors
JD Cox;CB Scott;B Emami;AH Russell;K Fu;M Parliament;R Komaki;L Gaspar
Journal / Conference
International Association of Lung Cancer 18:126(#491)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Toxicity in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).

Authors
R Byhardt;C Scott;WT Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton
Journal / Conference
International Association of Lung Cancer 18(1):64(#244)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Response, failure patterns and survival in five radiation therpay oncology group (RTOG) trials of sequential and/or concurrent chemotherpy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).

Authors
R Byhardt;P Kolesar;WT Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton
Journal / Conference
International Association of Lung Cancer 18(1):62(#238)
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Clinical Trials: A Congressional Focus of Need.

Authors
CA Coltman, Jr.
Journal / Conference
The Oncologist [Guest Editorial] 2(4):vii-viii
Year
1997
Research Committee(s)
Cancer Control
PMID
PMID10388059
Study Number(s)
SWOG-9217

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

Authors
B Barlogie;S Jagannath;DH Vesole;SH Naucke;BD Cheson;D Mattox;D Bracy;SE Salmon;J Jacobson;JJ Crowley;G Tricot
Journal / Conference
Blood 89(3):789-793
Year
1997
Research Committee(s)
Myeloma

Feasiblity and cost-effectiveness of outpatient autotransplants in multiple myeloma.

Authors
S Jagannath;DH Vesole;M Zhang;KR Desikan;N Copeland;M Jagannath;D Bracy;R Jones;J Crowley;G Tricot;B Barlogie
Journal / Conference
Bone Marrow Transplantation 20:445-450
Year
1997
Research Committee(s)
Myeloma

Some exploratory tools for survival analysis.

Authors
J Crowley;M LeBlanc;J Jacobson;SE Salmon
Journal / Conference
In Lecture Notes In Statistics :199-229
Year
1997
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30, SWOG-8624

Trisomy 6 as a primary karyotypic aberration in hematological disorders.

Authors
AN Mohamed;M Varterasian;S Dobin;T McConnell;S Wolman;C Rankin;D Head;M Slovak
Journal / Conference
Blood 90(10):219b(#3720)
Year
1997
Research Committee(s)
Leukemia